Vasopressin and Methylprednisolone for IHCA-new study

ILCOR was pleased to hear the results of the VAM-IHCA trial presented at simultaneously with the trials publication in JAMA (

Our congratulations to Lars Andersen, Asger Genfeldt and the research team for completing this important study. The editorial presented by Spyros Mentzelopoulos and Panel discussion which included ILCOR members Katherine Berg, Bernd Bottiger and Laurie Morrison provided important insights. ILCOR will carefully review the findings of this trial and the individual patient meta-analysis described in the presentation to inform future treatment recommendations.